[Non epidermotropic T lymphoma preceded for several years by hypereosinophilic syndrome].
Bagot
M
M
Service de Dermatologie, Hôpital Henri-Mondor, Créteil.
Bodemer
C
C
Wechsler
J
J
Divine
M
M
Haioun
C
C
Capesius
C
C
Saal
F
F
Cabotin
P
P
Roubertie
E
E
de Prost
Y
Y
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D004802:Eosinophilia / Q000150:complications*; D006801:Humans; D007037:Hypothyroidism / Q000150:complications; D007073:Immunoglobulin E / Q000032:analysis; D016130:Immunophenotyping; D007370:Interferon Type I / Q000627:therapeutic use; D016131:Lymphocyte Subsets; D016410:Lymphoma, T-Cell, Cutaneous / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D011701:PUVA Therapy; D014751:Vindesine / Q000008:administration & dosage
D000305:Adrenal Cortex Hormones; D007370:Interferon Type I; D007073:Immunoglobulin E; D003520:Cyclophosphamide; D014751:Vindesine
Lymphome t non épidermotrope précédé pendant plusieurs années par un syndrome hyperéosinophilique.